Mark McKenna - Director at Apogee Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
APGE on Nasdaq
All Insider Reports
All Insider Reports

Mark McKenna - trading volume in the past year for Apogee Therapeutics, Inc.

Holdings reported by Mark McKenna for Apogee Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20K $997K $49.85 Dec 12, 2024 Direct
Stock Option (Right to Buy) 10.4K Jun 5, 2024 Direct Common Stock

Transactions reported by Mark McKenna for Apogee Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.